Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
48
FUNC Quote, Financials, Valuation and Earnings
Last price:
$33.93
Seasonality move
:
1.94%
Day range:
$33.64 - $34.27
52-week range:
$19.17 - $36.49
Dividend yield:
2.41%
P/E ratio:
13.85x
P/S ratio:
3.04x
P/B ratio:
1.27x
Volume:
31.5K
Avg. volume:
22.2K
1-year change:
53.58%
Market cap:
$220.4M
Revenue:
$71.3M
EPS (TTM):
$2.46
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $63.2M | $67.3M | $72.9M | $75.7M | $71.3M | |
| Revenue Growth (YoY) | 6.32% | 6.47% | 8.38% | 3.77% | -5.72% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $25.5M | $23.1M | $26.5M | $26.4M | $30.4M | |
| Other Inc / (Exp) | -- | $535K | $1.3M | $94K | -$4.3M | |
| Operating Expenses | $25.5M | $23M | $24.6M | $26.4M | $30.3M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $16.5M | $17.8M | $26.3M | $33.2M | $19.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3.3M | $3.9M | $6.5M | $8.1M | $4.4M | |
| Net Income to Company | $13.1M | $13.8M | $19.8M | $25M | $15.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $13.1M | $13.8M | $19.8M | $25M | $15.1M | |
| Basic EPS (Cont. Ops) | $1.85 | $1.98 | $2.95 | $3.77 | $2.25 | |
| Diluted EPS (Cont. Ops) | $1.85 | $1.97 | $2.95 | $3.76 | $2.25 | |
| Weighted Average Basic Share | $7.1M | $7M | $6.7M | $6.7M | $6.7M | |
| Weighted Average Diluted Share | $7.1M | $7M | $6.7M | $6.7M | $6.7M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $28M | $27.4M | $32M | $38M | $43.8M | |
| Revenue (Reported) | $63.2M | $67.3M | $72.9M | $75.7M | $71.3M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $28M | $27.4M | $32M | $38M | $43.8M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $17.2M | $18.1M | $19.8M | $18.8M | $20.3M | |
| Revenue Growth (YoY) | 3.15% | 5.18% | 9.74% | -5.06% | 7.59% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $5.9M | $6.2M | $6.4M | $7.5M | $7.6M | |
| Other Inc / (Exp) | $575K | -$54K | $93K | -$45K | -$14K | |
| Operating Expenses | $5.8M | $3.8M | $6.4M | $7.5M | $7.6M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $6.4M | $5.8M | $9.6M | $5.8M | $7.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.4M | $1.4M | $2.7M | $1.3M | $1.9M | |
| Net Income to Company | $5M | $4.4M | $6.9M | $4.5M | $5.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $5M | $4.4M | $6.9M | $4.5M | $5.8M | |
| Basic EPS (Cont. Ops) | $0.70 | $0.66 | $1.04 | $0.67 | $0.89 | |
| Diluted EPS (Cont. Ops) | $0.70 | $0.66 | $1.04 | $0.67 | $0.89 | |
| Weighted Average Basic Share | $7M | $6.6M | $6.7M | $6.7M | $6.5M | |
| Weighted Average Diluted Share | $7M | $6.6M | $6.7M | $6.7M | $6.5M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $8.7M | $7.1M | $10.7M | $13M | $15.7M | |
| Revenue (Reported) | $17.2M | $18.1M | $19.8M | $18.8M | $20.3M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $8.7M | $7.1M | $10.7M | $13M | $15.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $66M | $70.2M | $75.5M | $76.2M | $73.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $23.3M | $23.2M | $27.6M | $30.3M | $31.1M | |
| Other Inc / (Exp) | $682K | -$47K | $1.3M | -$47K | -$4.2M | |
| Operating Expenses | $23.1M | $17.6M | $31.3M | $30.3M | $31.1M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $15.5M | $22.1M | $34.4M | $26.2M | $21.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3.4M | $5.4M | $8.8M | $5.9M | $5M | |
| Net Income to Company | $12.2M | $16.8M | $25.6M | $20.3M | $16.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $12.2M | $16.8M | $25.6M | $20.3M | $16.1M | |
| Basic EPS (Cont. Ops) | $1.73 | $2.53 | $3.86 | $3.04 | $2.46 | |
| Diluted EPS (Cont. Ops) | $1.73 | $2.53 | $3.86 | $3.02 | $2.46 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $26M | $29.1M | $37.9M | $44.7M | $53.1M | |
| Revenue (Reported) | $66M | $70.2M | $75.5M | $76.2M | $73.9M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $26M | $29.1M | $37.9M | $44.7M | $53.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $50M | $53M | $56M | $56.5M | $59M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $17.7M | $17.8M | $18.9M | $22.7M | $23.1M | |
| Other Inc / (Exp) | $682K | $100K | $96K | -$45K | -$14K | |
| Operating Expenses | $17.6M | $12.2M | $18.9M | $22.7M | $23.1M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $11.9M | $16.3M | $24.4M | $17.4M | $19.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.6M | $4M | $6.3M | $4.1M | $4.7M | |
| Net Income to Company | $9.3M | $12.2M | $18.1M | $13.3M | $14.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $9.3M | $12.2M | $18.1M | $13.3M | $14.4M | |
| Basic EPS (Cont. Ops) | $1.32 | $1.81 | $2.72 | $1.99 | $2.20 | |
| Diluted EPS (Cont. Ops) | $1.32 | $1.81 | $2.72 | $1.98 | $2.20 | |
| Weighted Average Basic Share | $21M | $20.2M | $19.9M | $20.1M | $19.6M | |
| Weighted Average Diluted Share | $21.1M | $20.2M | $20M | $20.1M | $19.7M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $19.4M | $21.1M | $27M | $33.7M | $43.1M | |
| Revenue (Reported) | $50M | $53M | $56M | $56.5M | $59M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $19.4M | $21.1M | $27M | $33.7M | $43.1M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $50M | $149.4M | $115.7M | $74.3M | $49.8M | |
| Short Term Investments | $131.3M | $226.9M | $286.8M | $125.9M | $97.2M | |
| Accounts Receivable, Net | $16.1M | $6.2M | $4.8M | $6.1M | $7.5M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $197.3M | $390M | $416M | $206.3M | $154.4M | |
| Property Plant And Equipment | $41.4M | $39.3M | $36.9M | $36.8M | $32.8M | |
| Long-Term Investments | $225.3M | $295.1M | $343M | $361.5M | $311.5M | |
| Goodwill | $11M | $11M | $12.1M | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.4B | $1.7B | $1.7B | $1.8B | $1.9B | |
| Accounts Payable | $20.2M | $16.7M | $15.8M | $151K | $612K | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $69.9M | $66.8M | $74.5M | $65.9M | $47.4M | |
| Long-Term Debt | $100.9M | $100.9M | $30.9M | $30.9M | $110.9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.3B | $1.6B | $1.6B | $1.7B | $1.7B | |
| Common Stock | $71K | $70K | $66K | $67K | $66K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $125.9M | $131M | $141.9M | $151.8M | $161.9M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $125.9M | $131M | $141.9M | $151.8M | $161.9M | |
| Total Liabilities and Equity | $1.4B | $1.7B | $1.7B | $1.8B | $1.9B | |
| Cash and Short Terms | $181.3M | $376.3M | $402.5M | $200.2M | $146.9M | |
| Total Debt | $100.9M | $100.9M | $30.9M | $30.9M | $110.9M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $155.6M | $134.9M | $30.8M | $80.7M | $62.4M | |
| Short Term Investments | $153.2M | $235.6M | $128M | $114.4M | $93.2M | |
| Accounts Receivable, Net | $19.2M | $22.9M | $5.2M | $6.7M | $7.1M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $328M | $393.4M | $164M | $201.7M | $162.6M | |
| Property Plant And Equipment | $39.9M | $37.5M | $37M | $34.7M | $31.9M | |
| Long-Term Investments | $222.4M | $297.5M | $366.5M | $330.1M | $267.2M | |
| Goodwill | $11M | $11M | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.7B | $1.7B | $1.8B | $1.9B | $1.9B | |
| Accounts Payable | $20.9M | $23.1M | $18.2M | $578K | $1.9M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $29M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $74.4M | $96.5M | $108.9M | $55.3M | $53.5M | |
| Long-Term Debt | $100.9M | $30.9M | $30.9M | $110.9M | $120.9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.6B | $1.6B | $1.7B | $1.8B | $1.7B | |
| Common Stock | $70K | $66K | $67K | $67K | $65K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $130.2M | $133.8M | $132M | $155M | $174M | |
| Total Liabilities and Equity | $1.7B | $1.7B | $1.8B | $1.9B | $1.9B | |
| Cash and Short Terms | $308.8M | $370.5M | $158.8M | $195M | $155.6M | |
| Total Debt | $100.9M | $30.9M | $30.9M | $110.9M | $149.9M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $13.1M | $13.8M | $19.8M | $25M | $15.1M | |
| Depreciation & Amoritzation | $3.4M | $3.6M | $3.4M | $3.6M | $4.9M | |
| Stock-Based Compensation | $268K | $345K | $472K | $532K | $527K | |
| Change in Accounts Receivable | -$3K | -$6.8M | -$1.6M | $648K | -$4.9M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $16.4M | $16.2M | $20M | $26.5M | $22.5M | |
| Capital Expenditures | $4M | $1.6M | $1.1M | $3.6M | $353K | |
| Cash Acquisitions | -- | -- | -- | -$600K | -- | |
| Cash From Investing | -$32.5M | -$191.3M | -$28.4M | -$172.4M | -$81.7M | |
| Dividends Paid (Ex Special Dividend) | -$3.1M | -$3.6M | -$3.9M | -$4M | -$5.2M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | $80M | |
| Long-Term Debt Repaid | -- | -- | -$70M | -- | -- | |
| Repurchase of Common Stock | -- | -$2.8M | -$7.2M | -- | -$1.5M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $42.6M | $274.6M | -$25.3M | $104.5M | $34.7M | |
| Beginning Cash (CF) | $23.5M | $50M | $149.4M | $115.7M | $74.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $26.4M | $99.5M | -$33.7M | -$41.4M | -$24.6M | |
| Ending Cash (CF) | $50M | $149.4M | $115.7M | $74.3M | $49.8M | |
| Levered Free Cash Flow | $12.4M | $14.6M | $18.9M | $23M | $22.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $5M | $4.4M | $6.9M | $4.5M | $5.8M | |
| Depreciation & Amoritzation | $838K | $904K | $970K | $996K | $830K | |
| Stock-Based Compensation | $52K | -$13K | $79K | $69K | -$63K | |
| Change in Accounts Receivable | $957K | -$1.1M | -$1.9M | $2.5M | -$2.3M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $5M | $3.8M | $8.3M | $8.7M | $2.3M | |
| Capital Expenditures | $68K | $85K | $547K | $62K | $1.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$7.9M | -$3.7M | -$44.8M | -$13.7M | -$24.7M | |
| Dividends Paid (Ex Special Dividend) | -$909K | -$992K | -$999K | -$1.3M | -$1.3M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $3.9M | $23M | -- | -- | $90M | |
| Long-Term Debt Repaid | -- | -$70M | -- | -- | -$40M | |
| Repurchase of Common Stock | -- | -- | -- | -$21K | $1K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $41.4M | -$59.6M | $45.6M | -$2.9M | $39.7M | |
| Beginning Cash (CF) | $117.1M | $194.4M | $21.7M | $88.6M | $45.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $38.5M | -$59.5M | $9.1M | -$7.9M | $17.3M | |
| Ending Cash (CF) | $155.6M | $134.9M | $30.8M | $80.7M | $62.4M | |
| Levered Free Cash Flow | $4.9M | $3.7M | $7.7M | $8.7M | $588K | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $12.2M | $16.8M | $25.6M | $20.3M | $16.1M | |
| Depreciation & Amoritzation | $3.3M | $3.6M | $3.8M | $3.8M | $5M | |
| Stock-Based Compensation | $289K | $513K | $498K | $540K | $474K | |
| Change in Accounts Receivable | $4M | -$5.8M | -$614K | -$455K | -$4.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $18.1M | $18.8M | $28.3M | $24.6M | $18.7M | |
| Capital Expenditures | $2.5M | $1.1M | $3.1M | $1.1M | $1.9M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$183.2M | -$45.7M | -$212.7M | -$77.6M | $1.3M | |
| Dividends Paid (Ex Special Dividend) | -$3.7M | -$3.8M | -$4M | -$4.9M | -$5.3M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $19.4M | -$23.2M | $80M | $90M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$2.8M | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $236.5M | $6.2M | $80.2M | $102.9M | -$38.3M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $71.4M | -$20.7M | -$104.2M | $49.9M | -$18.3M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $15.6M | $17.7M | $25.2M | $23.5M | $16.9M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $9.3M | $12.2M | $18.1M | $13.3M | $14.4M | |
| Depreciation & Amoritzation | $2.5M | $2.5M | $2.9M | $3M | $3.1M | |
| Stock-Based Compensation | $221K | $389K | $415K | $423K | $370K | |
| Change in Accounts Receivable | -$2.6M | -$1.6M | -$651K | -$1.8M | -$957K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $7.8M | $10.4M | $18.7M | $16.8M | $13M | |
| Capital Expenditures | $1.3M | $826K | $2.8M | $346K | $1.9M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$135.9M | $9.7M | -$174.6M | -$79.8M | $3.2M | |
| Dividends Paid (Ex Special Dividend) | -$2.7M | -$2.9M | -$3M | -$3.9M | -$4M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $3.9M | $23.2M | -- | $80M | $90M | |
| Long-Term Debt Repaid | -- | -$70M | -- | -- | -$80M | |
| Repurchase of Common Stock | -$2.8M | -$7.2M | -- | -$21K | -$4M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $233.8M | -$34.6M | $70.9M | $69.4M | -$3.6M | |
| Beginning Cash (CF) | $239.1M | $536.9M | $213.5M | $318.8M | $181.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $105.6M | -$14.5M | -$85M | $6.3M | $12.6M | |
| Ending Cash (CF) | $344.7M | $522.4M | $128.5M | $325.1M | $194.4M | |
| Levered Free Cash Flow | $6.5M | $9.6M | $15.9M | $16.4M | $11.2M | |
Get FUNC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
FUNC
Sector
P/E ratio
13.85x
12.02x
PEG ratio
--
0.36x
P/B ratio
1.27x
1.05x
Price / LTM sales
3.04x
2.55x
Growth Metrics
FUNC
Sector
Revenue growth
7.59%
6.08%
Earnings growth
32.84%
6.45%
Revenue (5-year growth)
3.72%
5.85%
Earnings forecast
$0.79
$0.56
Profitability
FUNC
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
5.71%
5.27%
Return on assets
0.85%
0.98%
Return on equity
9.84%
9.43%
Earnings Date
Last Earnings Date
Oct
21
Next Earnings Date
Feb
5
Estimated Next Earnings Date
Jan
20
Balance Sheet
FUNC
Sector
Total cash
$155.6M
$617M
Short term investments
$97.2M
$408.4M
Total assets
$1.9B
$4.5B
Long term debt
$149.9M
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 3.98% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 8.75% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 3.58% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
